Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

254 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
GF-15, a novel inhibitor of centrosomal clustering, suppresses tumor cell growth in vitro and in vivo.
Raab MS, Breitkreutz I, Anderhub S, Rønnest MH, Leber B, Larsen TO, Weiz L, Konotop G, Hayden PJ, Podar K, Fruehauf J, Nissen F, Mier W, Haberkorn U, Ho AD, Goldschmidt H, Anderson KC, Clausen MH, Krämer A. Raab MS, et al. Among authors: leber b. Cancer Res. 2012 Oct 15;72(20):5374-85. doi: 10.1158/0008-5472.CAN-12-2026. Epub 2012 Aug 31. Cancer Res. 2012. PMID: 22942257
Proteins required for centrosome clustering in cancer cells.
Leber B, Maier B, Fuchs F, Chi J, Riffel P, Anderhub S, Wagner L, Ho AD, Salisbury JL, Boutros M, Krämer A. Leber B, et al. Sci Transl Med. 2010 May 26;2(33):33ra38. doi: 10.1126/scitranslmed.3000915. Sci Transl Med. 2010. PMID: 20505215
(+)-Geodin from Aspergillus terreus.
Rønnest MH, Nielsen MT, Leber B, Mortensen UH, Krämer A, Clausen MH, Larsen TO, Harris P. Rønnest MH, et al. Among authors: leber b. Acta Crystallogr C. 2011 Mar;67(Pt 3):o125-8. doi: 10.1107/S0108270111005816. Epub 2011 Feb 23. Acta Crystallogr C. 2011. PMID: 21368412 Free article.
Evaluation of infectious complications in patients with myelodysplastic syndromes: a prospective cohort study from the Canadian MDS registry.
Mathur S, Christou G, Delage R, Elemary M, Finn N, Geddes M, Houston DS, Keating MM, Khalaf D, Leber B, Leitch H, Lother SA, Mozessohn L, Nevill T, Parmentier A, Paulson K, Rimmer E, Sabloff M, Shamy A, St-Hilaire E, Storring J, Yee K, Zhang L, Zhu N, Hay AE, Zarychanski R, Buckstein R, Houston BL. Mathur S, et al. Among authors: leber b. Ann Hematol. 2024 Nov 22. doi: 10.1007/s00277-024-06096-x. Online ahead of print. Ann Hematol. 2024. PMID: 39572410
Early Mixed Donor Chimerism is a Strong Negative Prognostic Indicator in Allogeneic Stem Cell Transplant for AML and MDS.
Radford M, Garcia-Horton A, Badami R, Jin E, Usmani N, Grafodatskaya D, McCready E, Khalaf D, Walker I, Leber B, Lepic K, Pond G, Berg T. Radford M, et al. Among authors: leber b. Transplant Cell Ther. 2024 Nov 14:S2666-6367(24)00759-0. doi: 10.1016/j.jtct.2024.11.006. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39547311 Free article.
Improvement in quality of life in MDS patients who become transfusion independent after treatment.
Wan BA, Alibhai SMH, Chodirker L, Mozessohn L, Geddes M, Zhu N, Trottier AM, St-Hilaire E, Finn N, Leber B, Khalaf D, Christou G, Sabloff M, Leitch HA, Shamy A, Yee KWL, Storring J, Nevill TJ, Houston BL, Elemary M, Delage R, Parmentier A, Siddiqui M, Mamedov A, Zhang L, Buckstein R. Wan BA, et al. Among authors: leber b. Leuk Lymphoma. 2024 Nov 9:1-10. doi: 10.1080/10428194.2024.2422844. Online ahead of print. Leuk Lymphoma. 2024. PMID: 39520728
Development of an evidence-based hepatitis C education program to enhance public health literacy in the Australian prison sector: The Hepatitis in Prisons Education program (HepPEd).
Sheehan Y, Lafferty L, Tedla N, Byrne M, Dawson O, Stewart S, Leber B, Habraken N, Lloyd AR. Sheehan Y, et al. Among authors: leber b. Int J Drug Policy. 2024 Jul;129:104461. doi: 10.1016/j.drugpo.2024.104461. Epub 2024 Jul 5. Int J Drug Policy. 2024. PMID: 38971019 Free article.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Hochhaus A, et al. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38820078 Clinical Trial.
Identification of cells of leukemic stem cell origin with non-canonical regenerative properties.
Hollands CG, Boyd AL, Zhao X, Reid JC, Henly C, ElRafie A, Boylan D, Broder E, Kalau O, Johnson P, Mark A, McNicol J, Xenocostas A, Berg T, Foley R, Trus M, Leber B, Garcia-Horton A, Campbell C, Bhatia M. Hollands CG, et al. Among authors: leber b. Cell Rep Med. 2024 Apr 16;5(4):101485. doi: 10.1016/j.xcrm.2024.101485. Epub 2024 Apr 5. Cell Rep Med. 2024. PMID: 38582086 Free PMC article.
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Levis MJ, Hamadani M, Logan B, Jones RJ, Singh AK, Litzow M, Wingard JR, Papadopoulos EB, Perl AE, Soiffer RJ, Ustun C, Ueda Oshima M, Uy GL, Waller EK, Vasu S, Solh M, Mishra A, Muffly L, Kim HJ, Mikesch JH, Najima Y, Onozawa M, Thomson K, Nagler A, Wei AH, Marcucci G, Geller NL, Hasabou N, Delgado D, Rosales M, Hill J, Gill SC, Nuthethi R, King D, Wittsack H, Mendizabal A, Devine SM, Horowitz MM, Chen YB; BMT-CTN 1506/MORPHO Study Investigators. Levis MJ, et al. J Clin Oncol. 2024 May 20;42(15):1766-1775. doi: 10.1200/JCO.23.02474. Epub 2024 Mar 12. J Clin Oncol. 2024. PMID: 38471061 Free PMC article. Clinical Trial.
254 results